LGBTQ+ Inclusive Policies Boost Mpox Vaccination Rates Across U.S. States
A study reveals that states with stronger LGBTQ+ protections in the US saw significantly higher mpox vaccination rates during the 2022–2023 outbreak, highlighting the importance of inclusive policies in public health.
A recent study highlights a significant link between LGBTQ+ equality laws and mpox vaccination rates in the United States during the 2022–2023 outbreak. Researchers from CUNY School of Public Health found that states with stronger legal protections for LGBTQ+ communities experienced notably higher vaccination uptake compared to those with fewer protections. Specifically, states with high LGBTQ+ equality had around four times the vaccination rates of states with less inclusive policies. This disparity persisted throughout different phases of the outbreak, indicating the integral role of social and policy environments in public health efforts.
The study analyzed over 1.2 million administered mpox vaccine doses across all 50 states and Washington, D.C. Interestingly, financial barriers were not a major obstacle since the vaccine was provided free nationwide. Instead, factors like societal stigma and mistrust in healthcare systems in less inclusive states likely contributed to lower vaccination levels.
Lead researcher Claudia Jimenez Castro emphasized that promoting health equity through supportive policies could enhance vaccine acceptance during health crises. Associate Professor Elizabeth Kelvin pointed out that improving legal protections for LGBTQ+ populations might be crucial in effective epidemic response strategies in the future.
This research underscores the importance of inclusive policies and environments that foster trust and participation in public health measures, especially among vulnerable communities. Strengthening such protections could lead to better health outcomes and more resilient responses to future outbreaks.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Finds GLP-1 Diabetes Medications May Lower Dementia Risk Compared to Metformin
New research suggests GLP-1 receptor agonists may be more effective than metformin in lowering dementia risk among individuals with type 2 diabetes, potentially leading to updated treatment guidelines.
Targeting Mitochondrial Protein VDAC2 Could Enhance Liver Cancer Treatments
Researchers have identified VDAC2, a mitochondrial protein, as a promising target to enhance selective liver cancer treatments, potentially improving patient outcomes with targeted therapy.
Household Mold as a Significant Cause of Hypersensitivity Pneumonitis
Indoor mold exposure significantly contributes to hypersensitivity pneumonitis, a serious lung disease. New research highlights the importance of environmental assessments and mold removal for patient health.
Including Extenders in Medical Articles Significantly Boosts Reader Engagement
Studies show that medical articles enhanced with digital extenders like infographics and videos receive over twice the number of views, emphasizing the importance of accessible research dissemination.